Physician

Narpinder Singh, MD

According to 2025 Medicare claims, Narpinder Singh, MD (NPI: 1518039791) practices cardiology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is ST. LUKE'S WARREN PHYSICIAN GROUP, PC (NPI: 1285061630; TIN: 22-3837316) and primary practice location at 08865-2748. Singh is affiliated with the St. Luke's Medicare ACO (ACO ID: A3560), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,457 traditional Medicare patients, billed 5,895 HCPCS/CPT codes, and received $220,893 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,578 prescription claims across 871 beneficiaries totaling $880,310 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 18 claims. Open Payments data shows 4 records totaling $69. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $485,816 to $220,893. In contrast, Part D prescription costs have moved sharply higher in recent years, from $255,415 to $880,310. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,583	6,266	$485,816
2016	1,433	5,166	$369,090
2017	2,042	6,483	$301,968
2018	1,992	6,445	$319,385
2019	1,900	6,690	$316,788
2020	1,634	5,452	$260,467
2021	1,608	5,527	$284,375
2022	1,477	4,892	$248,350
2023	1,497	6,203	$251,765
2024	1,457	5,895	$220,893

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	604	5,341	$255,415
2016	622	5,945	$322,356
2017	539	5,424	$297,944
2018	545	5,481	$386,441
2019	631	6,217	$507,683
2020	653	6,212	$563,591
2021	710	6,486	$637,198
2022	757	6,447	$757,871
2023	835	6,822	$903,745
2024	871	6,578	$880,310

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$35,610
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	394	499	$100
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	144	295	$70
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	317	322	$58
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	404	493	$12
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	671	1,043	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	490	26,068	$495,873
Xarelto	Rivaroxaban	138	8,763	$156,633
Entresto	Sacubitril/Valsartan	50	2,805	$61,585
Jardiance	Empagliflozin	41	2,115	$40,663
Metoprolol Succinate	Metoprolol Succinate	721	57,633	$11,860

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$69	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Narpinder Singh, MD?

Tedicare shows public-source Medicare data for Narpinder Singh, MD (NPI 1518039791), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Narpinder Singh, MD have ACO affiliation data?

Narpinder Singh, MD is shown with ACO affiliation data for St. Luke's Medicare ACO (MSSP, ACO ID A3560).

What billing organization is linked to Narpinder Singh, MD?

Narpinder Singh, MD is linked to ST. LUKE'S WARREN PHYSICIAN GROUP, PC (billing NPI 1285061630) in the available physician profile data.

Does Narpinder Singh, MD have Open Payments data?

Narpinder Singh, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.